Craig Byrd

Craig Byrd has extensive experience in the pharmaceutical and biotechnology industries, currently serving as a Neuroimmunology Specialty Account Manager at Amgen since September 2024. Prior to this role, Craig was a Duchenne Muscular Dystrophy Account Specialist at NS Pharma, Inc. from January 2023 to September 2024. Craig held various positions at ANI Pharmaceuticals, Strongbridge Biopharma plc, Merz North America, Allergan, AstraZeneca, and Ferndale Laboratories, with a focus on areas such as rare diseases, clinical account management, training, and sales in multiple therapeutic categories. Craig earned a Bachelor of Science degree in Criminal Justice from East Carolina University between 1988 and 1992.